Ronald Andrews

Clarient, Inc. provides cancer diagnostic testing services. It offers oncology diagnostic testing services to community pathologists, oncologists, biopharmaceutical companies, and researchers. The company was founded in 1993 and is headquartered in Aliso Viejo, CA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Insight Genetics, Inc. engages in the diagnosis, monitoring, and treatment of cancer. It specialize in the discovery, development, and commercialization of companion diagnostics. The company was founded in 2007 and is headquartered in Nashville, TN.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.